TOP STORIES

• REGULATORY Health Ministry Research Team to Vet Recall Rules to Address Supply Disruptions
  October 17, 2022

• BUSINESS Fujifilm Ditches Avigan COVID-19 Program, Pulls Submission in Japan
  October 17, 2022

• BUSINESS Fertility Drugs Face Supply Woes as Demand Spikes on Health Coverage
  October 14, 2022

• REGULATORY Govt Eyes Designation of Cefazolin, Other Antibiotics as Key Resources
  October 14, 2022

• REGULATORY MHLW Expert Panel Sorts Out Discussion Points for Full Debate; Focus on Innovation, Stable Supply, and Margins
  October 13, 2022

• ACADEMIA Japan Expert Sees Lecanemab Initially Treating Only a Few Tens of Thousands of Patients with Immature Care Setup
  October 12, 2022

• BUSINESS Kyushu Univ. Spinoff Aims to File NK-Like Cells in 2025, Eyes Combo with Checkpoint Drugs
  October 11, 2022

• REGULATORY Japan to Roll Out BA.4/5 Omicron Boosters on Oct. 13, Inoculations for 6 Months to 4 Years from Oct. 24
  October 11, 2022

• REGULATORY MHLW Panel to Discuss Shortening of COVID Booster Interval
  October 11, 2022

• ORGANIZATION EFPIA Chief Prods Japan on Mutual Trial Data Recognition, Cooperation to Boost Attractiveness to Rival US, China
  October 7, 2022

• REGULATORY Chuikyo Kicks Off Debate on FY2023 Off-Year Drug Price Revision
  October 6, 2022

• BUSINESS Moderna Files BA.4/5-Tailored COVID-19 Vaccine in Japan
  October 5, 2022

• REGULATORY Japan Panel OKs Inclusion of Silgard 9 into National Immunization Program
  October 5, 2022

• BUSINESS Novartis Homes in on 5 Therapy Areas and 4 Markets, Eyes Top 3 Multinational Rank in Japan: CEO
  October 4, 2022

• BUSINESS Celltrion Aims to Market 11 Biosimilars in Japan, Infliximab “Biobetter” in the List
  October 3, 2022

• REGULATORY Japan Ends Supply of AstraZeneca’s COVID Jab, 13.5 Million Doses Discarded
  October 3, 2022

• REGULATORY Wholesalers Question Inflexibility in Official Pricing, Sees Limit to Addressing Rising Costs
  September 30, 2022

• BUSINESS Ferring Japan CEO Confident of Growth in Fertility Drugs Spurred by Rising Demand on Health Coverage
  September 30, 2022

• BUSINESS Lecanemab Hits PIII Mark with 27% Cut in Clinical Decline, Eisai Set for Submissions by March-End
  September 29, 2022

• ORGANIZATION Policy Veterans’ Group Proposes Simple Drug Price Maintenance Scheme for Patented Meds
  September 28, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 64
• 65
• 66
• 67
• 68
• 69
• 70
• 71
• 72
• …
• Next ›
• 最終 »